keyword
https://read.qxmd.com/read/38657263/how-i-treat-philadelphia-chromosome-like-acute-lymphoblastic-leukemia-in-children-adolescents-and-young-adults
#1
JOURNAL ARTICLE
Thai Hoa Tran, Sarah K Tasian
Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) represents a high-risk B-lineage ALL subtype characterized by adverse clinical features and poor relapse-free survival despite risk-adapted multi-agent chemotherapy regimens. The advent of next-generation sequencing has unraveled the diversity of kinase-activating genetic drivers in Ph-like ALL that are potentially amenable to 'personalized' molecularly-targeted therapies. Based upon robust preclinical data and promising case series of clinical activity of tyrosine kinase inhibitor (TKI)-based treatment in adults and children with relevant genetic Ph-like ALL subtypes, several clinical trials have investigated the efficacy of JAK- or ABL-directed TKIs in CRLF2/JAK pathway-mutant or ABL-class Ph-like ALL, respectively...
April 24, 2024: Blood
https://read.qxmd.com/read/38657244/sequential-cd7-car-t-cell-therapy-and-allogeneic-hsct-without-gvhd-prophylaxis
#2
JOURNAL ARTICLE
Yongxian Hu, Mingming Zhang, Tingting Yang, Zhuomao Mo, Guoqing Wei, Ruirui Jing, Houli Zhao, Rongrong Chen, Cheng Zu, Tianning Gu, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Shan Fu, Delin Kong, Huijun Xu, Jiazhen Cui, Simao Huang, Bin Liang, Xiaolin Yuan, Qu Cui, Hongshan Guo, Yunxian Yu, Youqin Feng, Chunxiang Jin, Jiangtao Ren, Alex H Chang, Dongrui Wang, He Huang
BACKGROUND: Patients with relapsed or refractory hematologic cancers have a poor prognosis. Chimeric antigen receptor (CAR) T-cell therapy as a bridge to allogeneic hematopoietic stem-cell transplantation (HSCT) has the potential for long-term tumor elimination. However, pre-HSCT myeloablation and graft-versus-host disease (GVHD) prophylaxis agents have toxic effects and could eradicate residual CAR T cells and compromise antitumor effects. Whether the integration of CAR T-cell therapy and allogeneic HSCT can preserve CAR T-cell function and improve tumor control is unclear...
April 25, 2024: New England Journal of Medicine
https://read.qxmd.com/read/38656833/gene-expression-assays-to-tailor-adjuvant-endocrine-therapy-for-hr-her2-breast-cancer
#3
JOURNAL ARTICLE
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Adjuvant endocrine therapy represents the standard of care for almost all HR+/HER2- breast cancers and different agents and durations are currently available. In this context, the tailoring and optimization of adjuvant endocrine treatment by reducing unnecessary toxic treatment while taking into account the biological heterogeneity of HR+/HER2- breast cancer represents a clinical priority. There is therefore a significant need for the integration of biological biomarkers in the choice of adjuvant endocrine therapy beyond currently used clinicopathological characteristics...
April 24, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38656685/circulating-tumor-dna-in-diffuse-large-b-cell-lymphoma-from-bench-to-bedside
#4
REVIEW
Hua-Jay J Cherng, Alex Herrera
Diffuse large B-cell lymphoma (DLBCL) is a curable disease with variable outcomes due to underlying heterogeneous clinical and molecular features-features that are insufficiently characterized with our current tools. Due to these limitations, treatment largely remains a "one-size-fits-all" approach. Circulating tumor DNA (ctDNA) is a novel biomarker in cancers that is increasingly utilized for risk stratification and response assessment. ctDNA is readily detectable from the plasma of patients with DLBCL but has not yet been incorporated into clinical care to guide treatment...
April 24, 2024: Current Treatment Options in Oncology
https://read.qxmd.com/read/38654514/misdiagnosis-of-cutaneous-facial-sporotrichosis-an-analysis-of-five-cases
#5
JOURNAL ARTICLE
Weiwei Shi, Yunyan Zheng, Huiying Wang, Ruzhi Zhang
BACKGROUND: Facial cutaneous sporotrichosis presents with diverse clinical manifestations, often leading to misdiagnosis. OBJECTIVE: This study aims to present the clinical characteristics of five misdiagnosed cases of facial cutaneous sporotrichosis, aiming to enhance understanding of this disease and prevent misdiagnosis and mistreatment. METHODS: Clinical data, histopathology, and fungal culture results of these five cases were comprehensively analyzed...
April 23, 2024: Journal of Cosmetic Dermatology
https://read.qxmd.com/read/38653947/hepatic-and-extrahepatic-characteristics-of-autoimmune-hepatitis-a-23-year-hospital-based-cohort-study
#6
JOURNAL ARTICLE
Ming-Ling Chang, Puo-Hsien Le, Wei-Ting Chen, Tai-Di Chen, Rong-Nan Chien
BACKGROUND: The characteristics of autoimmune hepatitis (AIH) in Asia mostly remain elusive. METHODS: A cohort study of liver biopsy-proven AIH patients was conducted in a tertiary care cancer of Taiwan. RESULTS: From 1999 to 2022, of 13,766 patients who underwent liver biopsy, 150 patients with AIH were enrolled. The female-to-male ratio was 2.26. At baseline, the mean age was 51.09 years, mean alanine aminotransferase level was 494.11 U/L, and 17 (11...
April 23, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38652891/adalimumab-dose-reduction-and-withdrawal-in-stable-non-infectious-pediatric-uveitis-an-open-label-prospective-pilot-study
#7
JOURNAL ARTICLE
P D Yuan, Y W Hu, X Q Chen, G Y Chen, Y Pan, H Y Lao, D Liang
PURPOSES: This study investigated the feasibility of adalimumab (ADA) dose reduction and withdrawal strategy in children with stable pediatric non-infectious uveitis (PNIU). METHODS: This open-label prospective pilot trial recruited 18 stable PNIU patients (33 eyes) between two and eighteen years old who were treated with standard doses of ADA (20/40 mg every 2 weeks) plus oral methotrexate. The interval of ADA injection was extended to 4 weeks and followed up for 24 weeks...
April 23, 2024: Ocular Immunology and Inflammation
https://read.qxmd.com/read/38652054/car-t-therapy-followed-by-hematopoietic-stem-cell-transplantation-can-improve-survival-in-children-relapsed-refractory-philadelphia-chromosome-positive-b-cell-acute-lymphoblastic-leukemia
#8
JOURNAL ARTICLE
Yao Li, Guan-Hua Hu, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Pan Suo, Yu Wang, Yi-Fei Cheng, Xiao-Jun Huang
BACKGROUND: Philadelphia chromosome (Ph)-positive B-cell acute lymphoblastic leukemia (ALL) has a high complete remission (CR) rate, but relapse and prolonged measurable residual disease remain serious problems. We sought to describe the CR rate measurable residual disease negative rate and address the results and safety of pediatric patients who underwent after receiving chimeric antigen receptor (CAR) specific for CD19 (CAR-19) followed by hematopoietic stem cell transplantation (HSCT) for the treatment of Ph-positive ALL...
April 23, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38651622/pediatric-oropharyngeal-tularemia-cases-challenges-in-management
#9
JOURNAL ARTICLE
Soner Sertan Kara, Meltem Polat, Emine Hafize Erdeniz, Ayşe Sena Donmez
Background: Tularemia is one of the most prevalent zoonoses across the world. Patients in Turkiye mostly contract the oropharyngeal form, acquired through drinking, or contact with microorganism-contaminated water. Methods: Patients with oropharyngeal tularemia aged under 18 years and diagnosed between January 01, 2017, and December 31, 2020, were evaluated retrospectively. Tularemia was diagnosed in patients with compatible histories, symptoms, clinical presentations, and laboratory test results. Results: The mean age of 38 children was 12...
April 23, 2024: Vector Borne and Zoonotic Diseases
https://read.qxmd.com/read/38651452/post-transplant-cyclophosphamide-versus-anti-thymocyte-globulin-in-patients-with-hematological-malignancies-treated-with-allogeneic-hematopoietic-stem-cell-transplantation-from-haploidentical-and-matched-unrelated-donors-a-real-life-experience
#10
JOURNAL ARTICLE
Bianca Serio, Gabriella Storti, Matteo D'Addona, Lidia Santoro, Camilla Frieri, Danilo De Novellis, Luana Marano, Giovanna De Santis, Roberto Guariglia, Ilenia Manfra, Eleonora Urciuoli, Serena Luponio, Serena Marotta, Denise Morini, Michela Rizzo, Fausto Palmieri, Nicola Cantore, Valentina Giudice, Antonio Maria Risitano, Carmine Selleri
Background: Post-transplant cyclophosphamide (PTCY) is widely used as graft versus host disease (GvHD) prophylaxis in allogeneic hematopoietic stem cell transplant (HSCT) recipients, with reported clinical benefits in patients who underwent transplant from a matched unrelated donor (MUD). However, real-life data on clinical efficacy and safety of PTCY in haploidentical and MUD transplantations are still poor. Methods: In our real-life retrospective observational study, we included a total of 40 consecutive adult patients who underwent haploidentical or MUD HSCT for various hematological malignancies and who received PTCY ( n = 24) or ATG ( n = 16) as GvHD prophylaxis at Hematology Units from hospitals of Salerno and Avellino, Italy, and clinical outcomes were compared...
April 17, 2024: Hematology Reports
https://read.qxmd.com/read/38651177/effectiveness-and-infectious-complications-of-bcma-t-cell-engagers-in-treating-multiple-myeloma-real-world-evidence-from-sweden
#11
JOURNAL ARTICLE
Katarina Uttervall, Love Tätting, Konstantinos Lemonakis, Mousa Majd, Jacob Crafoord, Mikael Olsson, Ulf-Henrik Mellqvist, Markus Hansson, Hareth Nahi
BACKGROUND: Multiple myeloma (MM), an incurable disease characterized by frequent relapses and a need for multiple treatments, often progresses to a relapse/refractory status resistant to all available drugs and drug classes. Bispecific antibodies, specifically BCMA T-cell engagers, have emerged as effective treatments for MM, demonstrating impressive efficacy. However, these treatments can adversely affect the immune system, increasing vulnerability to infections. METHODS/RESULTS: This study evaluated the efficacy and safety of BCMA T-cell engagers in 58 Swedish patients with poor MM prognosis...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38651157/clinical-efficacy-and-safety-of-combined-anti-bcma-and-anti-cd19-car-t-cell-therapy-for-relapsed-refractory-multiple-myeloma-a-systematic-review-and-meta-analysis
#12
Han Xu, Chaoyang Guan, Peipei Xu, Dongming Zhou, Yong Xu, Bing Chen, Hua Bai
BACKGROUND: The low rates of durable response against relapsed/refractory multiple myeloma (RRMM) in recent studies prompt that chimeric antigen receptor (CAR)-T cell therapies are yet to be optimized. The combined anti-BCMA and anti-CD19 CAR-T cell therapy showed high clinical efficacy in several clinical trials for RRMM. We here conducted a meta-analysis to confirm its efficacy and safety. METHODS: We collected data from Embase, Web of Science, PubMed, CNKI, Wanfang and Cochrane databases up to April 2023...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38651147/co-operation-of-mcl-1-and-bcl-x-l-anti-apoptotic-proteins-in-stromal-protection-of-mm-cells-from-carfilzomib-mediated-cytotoxicity
#13
JOURNAL ARTICLE
Daria Galas-Filipowicz, Selina J Chavda, Jia-Nan Gong, David C S Huang, Asim Khwaja, Kwee Yong
INTRODUCTION: BCL-2 family proteins are important for tumour cell survival and drug resistance in multiple myeloma (MM). Although proteasome inhibitors are effective anti-myeloma drugs, some patients are resistant and almost all eventually relapse. We examined the function of BCL-2 family proteins in stromal-mediated resistance to carfilzomib-induced cytotoxicity in MM cells. METHODS: Co-cultures employing HS5 stromal cells were used to model the interaction with stroma...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38650415/-testicular-involvement-in-pediatric-lymphoid-tumors-a-review-of-the-literature-and-a-series-of-clinical-observation
#14
JOURNAL ARTICLE
S Korneeva M, A Batmanova N, R Panferova T, T Valiev T
Lymphoid tumors with testicular involvement in childhood are rare and heterogeneous. The disease may manifest with uni- or bilateral scrotal enlargement. Comprehensive examination includes evaluation of all lymph nodes involvement, as well as ultrasound examination, magnetic resonance imaging and positron emission tomography. A diagnosis is made on basis of morphological and immunohistochemical verification. Determination of lymphoid tumor variant and stage, is recommended to perform chemotherapy according to prognostic risk group, and, in some cases, transplantation of hematopoietic stem cells is required as consolidation therapy...
March 2024: Urologii︠a︡
https://read.qxmd.com/read/38650409/-evaluation-of-the-effectiveness-of-various-regimens-of-the-immunomodulatory-drug-superlimf-in-the-prevention-of-relapses-of-chronic-abacterial-prostatitis
#15
JOURNAL ARTICLE
A Gyaurgiev T, V Kuzmenko A, V KuzmenkoV, V Zolotukhin O, Yu Madykin Yu, I Avdeev A
INTRODUCTION: Immune defense mechanisms, including a decrease in the functional activity of monocytes/macrophages, neutrophils, as well as a violation of the balance of pro- and anti-inflammatory cytokines, are important in the development of chronic abacterial prostatitis (CAP). The discovery of the cytokine system and the determination of their biological role in the development and functioning of the immune system and in the pathogenesis of a wide range of human diseases led to the development of a new direction in immunotherapy - cytokine therapy...
March 2024: Urologii︠a︡
https://read.qxmd.com/read/38649886/lung-cancer-in-older-patients-with-granulomatosis-with-polyangiitis-a-report-of-three-cases
#16
JOURNAL ARTICLE
Malgorzata Potentas-Policewicz, Malgorzata Szolkowska, Katarzyna Blasinska, Dariusz Gawryluk, Malgorzata Sobiecka, Justyna Fijolek
BACKGROUND: Granulomatosis with polyangiitis (GPA) is characterized by necrotizing granulomatous inflammation with necrotizing vasculitis predominantly affecting small to medium vessels. The survival rates have drastically improved; however, GPA can be lethal, with older patients having a worse prognosis and higher mortality than younger patients. Moreover, the incidence of various cancers has been reported to increase in patients with GPA. We aimed to discuss possible associations between GPA and lung cancer and emphasize the associated diagnostic challenges...
April 22, 2024: BMC Pulmonary Medicine
https://read.qxmd.com/read/38648898/treosulfan-versus-busulfan-based-conditioning-in-allogeneic-hematopoietic-cell-transplantation-for-myelodysplastic-syndrome-a-single-center-retrospective-propensity-score-matched-cohort-study
#17
JOURNAL ARTICLE
Ivan Pasic, Tommy Alfaro Moya, Mats Remberger, Carol Chen, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Wilson Lam, Arjun Datt Law, Jeffrey H Lipton, Fotios V Michelis, Igor Novitzky-Basso, Auro Viswabandya, Jonas Mattsson
Treosulfan has shown promise in allogeneic hematopoietic cell transplantation (HCT) for its myeloablative properties and low toxicity. In this single-center retrospective propensity score-matched cohort study we compared treosulfan- and busulfan-based conditioning in allogeneic HCT for patients with myelodysplastic syndrome (MDS). This study included 138 adults who underwent allogeneic HCT for MDS or chronic myelomonocytic leukemia (CMML) at Princess Margaret Hospital, Toronto 2015-2022. Using propensity score matching, we compared transplant outcomes between two well-matched cohorts who received conditioning with either fludarabine-treosulfan (FT) (n=46) or fludarabine-busulfan with total body irradiation (FBT200) (n=92)...
April 20, 2024: Transplantation and cellular therapy
https://read.qxmd.com/read/38648252/effects-of-brief-mindfulness-training-on-smoking-cue-reactivity-in-tobacco-use-disorder-study-protocol-for-a-randomized-controlled-trial
#18
JOURNAL ARTICLE
Linlin Cheng, Miaoling Luo, Jie Ge, Yu Fu, Quan Gan, Zhuangfei Chen
BACKGROUND: The prevalence of Tobacco Use Disorder (TUD) represents a significant and pressing global public health concern, with far-reaching and deleterious consequences for individuals, communities, and healthcare systems. The craving caused by smoking cue is an important trigger for relapse, fundamentally hindering the cessation of cigarette smoking. Mindfulness interventions focusing on cue-reactivity was effective for the treatment of related dependence. Brief mindfulness training (BMT) meets the short-term needs for intervention but the effects still need to be examined...
2024: PloS One
https://read.qxmd.com/read/38647464/changing-vistas-of-psychosis-and-antipsychotic-drug-dosing-toward-personalized-management-of-antipsychotics-in-clinical-practice
#19
JOURNAL ARTICLE
Lex Wunderink
OBJECTIVE: To discuss current evidence on tapering antipsychotic drugs in view of changing vistas of psychosis, suggesting a provisional framework for safely tapering antipsychotic drugs to an optimal low dose, in collaboration with patients and their relatives, to promote functional recovery while preventing relapse. METHODS: Paradigm shifts during recent years regarding the nature of psychotic disorders and the role of the dopamine system are discussed, including the positive effects of dopamine blockade in acute psychosis and the limitations and drawbacks of dopamine blockade regarding negative and cognitive symptoms after remission of positive symptoms...
April 22, 2024: Psychiatric Rehabilitation Journal
https://read.qxmd.com/read/38647187/porphyria-cutanea-tarda-in-scotland-underlying-associations-and-treatment-approaches
#20
JOURNAL ARTICLE
Chayada Chaiyabutr, Robert Dawe, Sally H Ibbotson, Tara Clarke, Victoria A McGuire
BACKGROUND: Despite its rarity, porphyria cutanea tarda (PCT) is globally recognized as the most common form of cutaneous porphyria. This study aims to review the underlying associations and treatment of PCT in Scotland. METHODS: We retrospectively reviewed data on 27 patients diagnosed with PCT between 1987 and 2022 at the Scottish Cutaneous Porphyria Service. RESULTS: Males slightly predominated (66.7%). The mean ± standard deviation (SD) age at diagnosis was 55...
April 22, 2024: International Journal of Dermatology
keyword
keyword
18111
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.